Normalization of the Tumor Marker CA-125 after Oophorectomy in a Patient with Paraneoplastic Cerebellar Degeneration without Detectable Cancer
- 30 April 1997
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 65 (1) , 173-176
- https://doi.org/10.1006/gyno.1997.4618
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.Journal of Clinical Oncology, 1996
- The E. Graeme Robertson LectureJournal of Clinical Neuroscience, 1996
- Paraneoplastic Cerebellar DegenerationCanadian Journal of Neurological Sciences, 1993
- Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodiesThe Lancet, 1993
- Paraneoplastic cerebellar degeneration.Neurology, 1992
- Anti-Hu-Associated Paraneoplastic Encephalomyelitis/Sensory Neuronopathy A Clinical Study of 71 PatientsMedicine, 1992
- A variant of the anti‐Purkinje cell antibody in a patient with paraneoplastic cerebellar degenerationNeurology, 1988
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinomaAnnals of Neurology, 1983
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983